Participants 74 86 3
osteoporosis
Participants 478 653 7
Consecutive post-menopausal women aged 50 years to 86 years starting treatment with raloxifene according to daily practice were enrolled from 126 primary care offices in Spain
Participants 931 1043 5
A total of 745 post-menopausal women (group A, n=366; group B n=379), with a mean age of 62 years, were included
